These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 7527767)

  • 1. Somatosensory evoked potentials at rest and during movement in Parkinson's disease: evidence for a specific apomorphine effect on the frontal N30 wave.
    Cheron G; Piette T; Thiriaux A; Jacquy J; Godaux E
    Electroencephalogr Clin Neurophysiol; 1994 Nov; 92(6):491-501. PubMed ID: 7527767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in the amplitude of the N30 frontal component of SEPs during apomorphine test in parkinsonian patients.
    de Mari M; Margari L; Lamberti P; Iliceto G; Ferrari E
    J Neural Transm Suppl; 1995; 45():171-6. PubMed ID: 8748623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Median nerve somatosensory evoked potentials. Apomorphine-induced transient potentiation of frontal components in Parkinson's disease and in parkinsonism.
    Rossini PM; Bassetti MA; Pasqualetti P
    Electroencephalogr Clin Neurophysiol; 1995 May; 96(3):236-47. PubMed ID: 7750449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parkinson's disease and somatosensory evoked potentials: apomorphine-induced transient potentiation of frontal components.
    Rossini PM; Traversa R; Boccasena P; Martino G; Passarelli F; Pacifici L; Bernardi G; Stanzione P
    Neurology; 1993 Dec; 43(12):2495-500. PubMed ID: 8255446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apomorphine-induced relief of the akinetic-rigid syndrome and early median nerve somatosensory evoked potentials (SEPs) in Parkinson's disease.
    Mauguière F; Broussolle E; Isnard J
    Electroencephalogr Clin Neurophysiol; 1993; 88(4):243-54. PubMed ID: 7688279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of deep brain stimulation on the frontal N30 component of somatosensory evoked potentials in advanced Parkinson's disease patients.
    Pierantozzi M; Mazzone P; Bassi A; Rossini PM; Peppe A; Altibrandi MG; Stefani A; Bernardi G; Stanzione P
    Clin Neurophysiol; 1999 Oct; 110(10):1700-7. PubMed ID: 10574285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curariform peripheral block of muscular tone selectively increases precentral N30 somatosensory evoked potentials component. A pharmacological study carried out on healthy subjects and parkinsonian syndromes.
    Pierantozzi M; Sabato AF; Leonardis F; Marciani MG; Cicardi C; Giacomini P; Bernardi G; Stanzione P
    Exp Brain Res; 2000 Aug; 133(3):368-76. PubMed ID: 10958527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Somatosensory evoked potentials and symptomatic response to dopaminergic drugs in Parkinson's disease].
    Castillo JL; Miranda CM; Araya F; Sáez D
    Rev Med Chil; 1996 Mar; 124(3):301-6. PubMed ID: 9008941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatosensory input to non-primary motor areas is enhanced during preparation of cued contraterlateral finger sequence movements.
    Brown MJ; Staines WR
    Behav Brain Res; 2015 Jun; 286():166-74. PubMed ID: 25746454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The selective gating of the N30 cortical component of the somatosensory evoked potentials of median nerve is different in the mesial and dorsolateral frontal cortex: evidence from intracerebral recordings.
    Kanovský P; Bares M; Rektor I
    Clin Neurophysiol; 2003 Jun; 114(6):981-91. PubMed ID: 12804666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time course of frontal somatosensory evoked potentials. Relation to L-dopa plasma levels and motor performance in PD.
    Ulivelli M; Rossi S; Pasqualetti P; Rossini PM; Ghiglieri O; Passero S; Battistini N
    Neurology; 1999 Oct; 53(7):1451-7. PubMed ID: 10534250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N30 wave amplitude of somatosensory evoked potentials from median nerve in Parkinson's disease: a pharmacological study.
    Traversa R; Pierantozzi M; Semprini R; Loberti M; Cicardi MC; Bassi A; Stanzione P
    J Neural Transm Suppl; 1995; 45():177-85. PubMed ID: 8748624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lateralization of the P22/N30 precentral cortical component of the median nerve somatosensory evoked potentials is different in patients with a tonic or tremulous form of cervical dystonia.
    Kañovský P; Streitová H; Dufek J; Znojil V; Daniel P; Rektor I
    Mov Disord; 1999 Jul; 14(4):642-51. PubMed ID: 10435502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N30 somatosensory evoked potentials in patients with unilateral Parkinson's disease.
    Drory VE; Inzelberg R; Groozman GB; Korczyn AD
    Acta Neurol Scand; 1998 Feb; 97(2):73-6. PubMed ID: 9517855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormality of N30 somatosensory evoked potentials in Parkinson's disease: a multidisciplinary approach.
    Bostantjopoulou S; Katsarou Z; Zafiriou D; Gerasimou G; Alevriadou A; Georgiadis G; Kiosseoglou G; Kazis A
    Neurophysiol Clin; 2000 Dec; 30(6):368-76. PubMed ID: 11191929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal premovement gating of somatosensory input in writer's cramp.
    Murase N; Kaji R; Shimazu H; Katayama-Hirota M; Ikeda A; Kohara N; Kimura J; Shibasaki H; Rothwell JC
    Brain; 2000 Sep; 123 ( Pt 9)():1813-29. PubMed ID: 10960045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SEPs N30 amplitude in Parkinson's disease and in pharmacologically induced rigidity: relationship with the clinical status.
    Stanzione P; Traversa R; Pierantozzi M; Semprini R; Loberti M; Peppe A; Santilli AM; Bernardi G
    Eur J Neurol; 1997 Jan; 4(1):24-38. PubMed ID: 24283819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Astereognosis and dissociated loss of frontal or parietal components of somatosensory evoked potentials in hemispheric lesions. Detailed correlations with clinical signs and computerized tomographic scanning.
    Mauguière F; Desmedt JE; Courjon J
    Brain; 1983 Jun; 106 (Pt 2)():271-311. PubMed ID: 6850271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-dominant hand movement facilitates the frontal N30 somatosensory evoked potential.
    Legon W; Dionne JK; Meehan SK; Staines WR
    BMC Neurosci; 2010 Sep; 11():112. PubMed ID: 20822535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The frontal N30 component of the median-derived SEP in patients with predominantly unilateral Parkinson's disease.
    Garcia PA; Aminoff MJ; Goodin DS
    Neurology; 1995 May; 45(5):989-92. PubMed ID: 7746421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.